Skip to main content
Premium Trial:

Request an Annual Quote

Strand Genomics Forms Collaboration with MediBic

NEW YORK, Aug 2 (GenomeWeb News) - Strand Genomics said today that it has formed a collaboration with Japanese pharmacogenomics services company MediBic to provide bioinformatics and data mining solutions in Japan


Under the terms of the deal, Strand and MediBic will jointly develop products and technologies for their drug discovery and development customers. Additionally, they will provide consulting in the areas of genomics, proteomics, clinical studies, predictive ADME/toxicology, and other pharmaceutical research and development areas, said Bangalore, India-based Strand.


Financial terms of the arrangement were not disclosed.


"One of MediBic's [goals] has been to strengthen its informatics and pharmacogenomics capabilities through key strategic partnerships," Yasuhiro Hashimoto, president and CEO of MediBic, said in a statement. "This partnership provides us with the platform to offer an integrated discovery and development system."


The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.